Praxis Precision Medicines (PRAX) cash on hand

Cash · fiscal 2025
$599.33M

Praxis Precision Medicines (PRAX) held cash of $599.33M at the end of fiscal 2025 (December 31, 2025). That is 52.7% higher than the $392.57M of fiscal 2024. Figures as of 18 Nov 2026, 04:53 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Cash, fiscal 2025
$599.33M
Change on fiscal 2024
+52.7%
Highest on record
$599.33Mfiscal 2025
Lowest on record
$81.30Mfiscal 2023
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Praxis Precision Medicines cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $599.33M in fiscal 2025 and the lowest $81.30M in fiscal 2023.

History · 4 fiscal years

Cash by fiscal year

Praxis Precision Medicines cash on hand, year by year

Praxis Precision Medicines (PRAX) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$599.33M 52.7% up
2024$392.57M 382.9% up
2023$81.30M 19.1% down
2022$100.49M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

Cash at health care companies of similar size

Cash of Praxis Precision Medicines and comparable companies
CompanyCashFiscal year
Oscar Health OSCR$3.99B2025
TG Therapeutics TGTX$141.97M2025
Praxis Precision Medicines PRAX$599.33M2025
Twist Bioscience TWST$581.91M2026
Protagonist Therapeutics PTGX$567.36M2025
Krystal Biotech KRYS$827.79M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PRAX

Praxis Precision Medicines, figure by figure

Praxis Precision Medicines (PRAX) overview: price, valuation and scorecardAll health care companies by market value

Praxis Precision Medicines cash on hand: questions and answers

How much cash does Praxis Precision Medicines have?

Praxis Precision Medicines (PRAX) held cash of $599.33M at the end of fiscal 2025 (December 31, 2025). That is 52.7% higher than the $392.57M of fiscal 2024.

What are the highest and lowest cash figures on record for Praxis Precision Medicines?

Across the 4 fiscal years on record (2022–2025), the highest was $599.33M in fiscal 2025 and the lowest $81.30M in fiscal 2023.

How is Praxis Precision Medicines's cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Praxis Precision Medicines (PRAX) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/PRAX/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.